Yahoo Finance 
Outlook on the Cardiac Resynchronization Therapy Devices Global Market to 2027 - Rising Prevalence of Cardiovascular Diseases is a Main Driving Factor
Global Cardiac Resynchronization Therapy (CRT) Devices Market
Dublin, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The "Global Cardiac Resynchronization Therapy (CRT) Devices Market - Analysis By Product (CRT-D, CRT-P), End-User By Region, By Country (2022 Edition): Market Insights and Forecast with Impact of COVID-19 (2022-2027)" report has been added to ResearchAndMarkets.com's offering.
The Global Cardiac Resynchronization Therapy (CRT) Devices Market was valued at USD 7.14 Billion in the year 2021 with Americas region leading the regional market share. One of the main factors driving this market is the rising prevalence of cardiovascular diseases (CVDs) that lead to heart failure (HF).
Each year, approximately 3.5 million people suffer from HF worldwide fostering the demand for cardiac resynchronization therapy devices. Additionally, factors such as technological advancements in devices, expanding CRT product developments, key company initiatives & investments, sedentary lifestyles and ageing demographics around the world are anticipated to impel the market growth in the forecast period.
The Asia Pacific CRT devices market is predicted to be the hotspot and the most lucrative region for the market participants worldwide. Some of the major factors propelling the growth of the cardiac resynchronization therapy devices market in the Asia Pacific region include a favourable reimbursement scenario in Japan, an ageing population in China, an increase in CVD incidence, an improved healthcare infrastructure, an expanding middle-class population, and rising disposable income levels in India.
The cardiac resynchronization therapy (CRT) devices market experienced a period of a temporary setback in the year 2020 as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19 virus. However, after the initial shock and confusion about COVID-19, companies and governments began taking corrective actions to help the economy and businesses recover.
These measures included policy & monetary stimulus, easing of restrictions, conditional exemptions, and other strategic initiatives. This resulted in healthcare activities returning to normal pace towards the end of 2020 with the approval and administration of COVID-19 vaccines across the globe, thereby offering better growth prospects for the cardiac resynchronization therapy devices market during the forecast period.
Scope of the Report:
The report presents the analysis of Cardiac Resynchronization Therapy Devices Market for the historical period of 2017-2021 and the forecast period of 2022-2027.
The report analyses the Cardiac Resynchronization Therapy Devices Market by value (USD Billion).
The report analyses the Cardiac Resynchronization Therapy Devices Market by value (USD Billion).
The report analyses the Cardiac Resynchronization Therapy Devices Market by Product Type (CRT-Defibrillator and CRT-Pacemaker).
The report analyses the Cardiac Resynchronization Therapy Devices Market by End User (Hospitals, Cardiac Centres and Research & Laboratories).
The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Region (Americas, Europe, Asia Pacific, MEA).
The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Product and by End User.
Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
The report tracks competitive developments, strategies, and Major Products & Developments and Mergers & Acquisitions. The companies analysed in the report include Medtronic, Boston Scientific Corp., Abbott Laboratories, Biotronik, MicroPort Scientific Corporation, Medico S.p.A, LivaNova and EBR Systems.
Key Topics Covered:
1. Report Scope and Methodology
2. Strategic Recommendations
3. Cardiac Resynchronization Therapy Devices Market: Product Overview
4. Global Cardiac Resynchronization Therapy Devices Market: An Analysis
4.1. Assessment of Macro Economic Indicators of Global Cardiac Resynchronization Therapy Devices Market
4.2 Global Cardiac Resynchronization Therapy Devices Market, Market Size, By Value, 2017-2027
4.3 Global Cardiac Resynchronization Therapy Devices Market, Market Size, By Volume, (Million Units), 2017-2027
4.4 Global Cardiac Resynchronization Therapy Devices Market: Growth and Forecast
4.5 Impact of COVID-19 on Global Cardiac Resynchronization Therapy Devices Market
5. Global Cardiac Resynchronization Therapy Devices Market Segmentation, By Product (Value)
5.1 Global Cardiac Resynchronization Therapy Devices Market Segmentation, By Product
5.2 Competitive Positioning of Cardiac Resynchronization Therapy Devices Market: By Product (2021 & 2027)
5.3 By CRT-Defibrillator, By Value (USD Billion), 2017-2027
5.4 By CRT-Pacemaker, By Value (USD Billion), 2017-2027
6. Global Cardiac Resynchronization Therapy Devices Market Segmentation, By End User (Value)
6.1 Global Cardiac Resynchronization Therapy Devices Market Segmentation, By End-User
6.2 Competitive Positioning of Global Cardiac Resynchronization Therapy Devices Market, By End-User (2021 & 2027)
6.3 By Hospitals, By value (USD Billion), 2017-2027
6.4 By Cardiac Centers, By Value (USD Billion), 2017-2027
6.5 By Research & Laboratories, By Value (USD Billion), 2017-2027
7. Global Cardiac Resynchronization Therapy Devices Market: Regional Analysis
7.1 Competitive Scenario of Global Cardiac Resynchronization Therapy Devices Market: By Region (2021 & 2027)
8. Americas Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
9. Europe Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
10. Asia Pacific Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
11. MEA Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
12. Global Cardiac Resynchronization Therapy Devices Market Dynamics
12.1 Global Cardiac Resynchronization Therapy Devices Market Drivers
12.2 Global Cardiac Resynchronization Therapy Devices Market Restraints
12.3 Global Cardiac Resynchronization Therapy Devices Market Trends
13. Market Attractiveness and Strategic Analysis
13.1 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By Product (Year 2027)
13.2 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By End User (Year 2027)
13.3 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By Region (Year 2027)
13. Competitive Landscape
13.1 Market Share of global leading companies
13.2 SWOT Analysis- Global Cardiac Resynchronization Therapy Devices Market
14. Global Cardiac Resynchronization Therapy Devices Market: Competitive Landscape
14.1 Market Share of global leading companies
14.2 Recent Developments and Mergers & Acquisitions
14.3 Prominent Companies Worldwide Unit Sales of CRT Devices in FY 2021
15. Company Profiles (Business Description, Financial Analysis, Business Strategy)
15.1 Medtronic PLC
15.2 Boston Scientific
15.3 Abbott Laboratories
15.4 Biotronik
15.5 MicroPort Scientific Corporation
15.6 LivaNova PLC
15.7 Medico S.p.A
15.8 EBR Systems
16. About the Publisher
For more information about this report visit https://www.researchandmarkets.com/r/8ge4n8
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
